Nano Today
Volume 29, December 2019, 100795
Journal home page for Nano Today

Review
Nanoparticles-based magnetic and photo induced hyperthermia for cancer treatment

https://doi.org/10.1016/j.nantod.2019.100795Get rights and content

Highlights

  • Mechanisms of magnetic and photo-induced hyperthermia for designing relevant nanomaterials.

  • Comprehensive comparison between both modalities and requirement for clinical translation.

  • Illustrations of different nanoparticles for both modalities of therapy.

  • Advocate the combining two modalities as a novel avenue for research.

Abstract

Nanoscience provides several modalities to combat cancer disease effectively. Magnetic hyperthermia and photothermal therapy techniques are central research themes among various groups in the world by utilizing magnetic and optical characteristics of distinct or composite nanoentities. This review provides the current research on both the techniques and their successes towards clinical translation. This review discusses about the various heating mechanisms involved in magnetic and photo-induced hyperthermia. We have evaluated potential functional nanoparticles with excellent properties capable of providing innovative future solutions to current problems associated with these therapies. Several factors (extracellular and intracellular) have been covered and explained which may affect such thermal treatments. We have provided some instrumental and technical details of both the techniques that are important for consideration in using these modalities of treatments. A direct comparison of these two techniques and a further need of the combined therapy (magnetic hyperthermia plus photothermal therapy) was highlighted as a new pathway for cancer treatments.

Introduction

Temperature is one of the basic variables in science and with the latest advancements in nanothermometry nowadays it can be measured with submicrometric spatial resolution [1]. The resolution in temperature measurements expands the applications and control of temperature changes in biological systems leading to a detailed determination of their dynamics and viability for a wide range of organic systems from cells, tissues to organisms [2]. The use of heat for the purpose of therapy is an old fashion methodology in ancient history which had a rise of popularity through the 19th century as a treatment against cancer, being optimized in 21st century, but still remained unaccomplished due to the lack of measuring methodologies [3]. In recent decades of “the nanoscale era”, the research activities in terms of scientific/technological output using thermal treatments have led to renewed interest in thermal therapy, especially on the magnetic-thermal therapy and photo-induced thermal therapy [4]. Novel techniques for controlled and localized heat generation, monitoring it, and transferring localized heat to the biological targets are being proposed purposely and specified. The understanding of different mechanisms causing temperature induced cell killing, cell-modification and the capability to produce heat in the vicinity of cells is very important. The type of nanoscale materials used to generate heat from external force such as magnetic field, infrared (IR) radiation, X-rays etc., are the main focus of research in the field [5]. The basic mechanism of thermal therapy is sometime controversial due to a lack of comprehensive understanding of the local effects caused by the temperature elevation on individual cells in most of the given bio-specimen [6]. All thermal treatments are based on driving part of the body or the whole above its normal temperature for a defined period of time. Temperature rise at cellular level causes changes in tissue elasticity, blood flow rate, protein synthesis, dissociation and inactivity of cells from minutes to several hours or days. The essential points in using thermal treatment are: the amount of localized temperature rise in biosystems and the duration of treatment in external field force. The magnitude of the temperature gradient is the primary factor that classifies thermal treatments and their macroscopic effects on cancer cells/tumors in three major categories:

  • (1)

    Diathermic treatment: It is based on heating tissues and organs from the standard body temperature up to 41 °C. These processes increase blood flow and cause a rise in the diffusion rates of “bio-liquids” across cell membranes but generally preserve the cellular homeostasis [6].

  • (2)

    Hyperthermia Treatment (HT): It is required the local generation of temperature in the range from 41 to 48 °C which is generally described as clinically relevant [7]. A comprehensive understanding of the biomechanisms acting at the cellular level in this range of temperature is still far from completion. In this temperature range, because of protein denaturation, aggregation and the synthesis of heat-shock proteins, long time treatments may lead to long term cell inactivation and change in the rates of several biochemical reactions. Hyperthermia treatments commonly used in combination with other cancer treatments such as chemotherapy or radiation therapy which are applied after due to increased susceptibility to the treatments of the heat stressed cells [8].

  • (3)

    Irreversible thermal treatment: It includes all treatments that increase the tumor temperature above 48 °C for a relatively short time. At this temperature range the effect on cells/tissues is drastic and non-reversible [9]. Irreversible thermal treatments can be very efficient in the ablation of tumors but sometimes they may cause secondary damages to DNA and proteins of healthy cells. So far that irreversible thermal treatments are not generally used for cancer treatment but primarily only in urology and cardiology as option to the traditional surgery [10].

Besides direct thermal-induced therapy, there are several other techniques and methodologies which contribute to the efficiency of hyperthermia as a therapeutic tool against cancer diseases such as oxygenation, pH-maintenance, photodynamic therapy, heat released chemotherapy, etc. [7]. Compared with others, thermal therapy is less invasive, and it increases the efficacy of traditional treatments by reducing side effects. Using a sufficiently accurate control, thermal therapy has been used for localized heating of cancer cells with minimal effect on normal cells [12]. Heating on superficial tumors can be done using radio frequencies, microwave irradiation, ultrasound techniques or with IR laser sources [13]. Depending on the depth and size of cancerous tissue, several parameters in instrumental setup can be varied in order to get a more effective treatment. Figs. 1a &1b explain the fundamental experimental arrangements of the magnetic hyperthermia treatment (MHT) as well as the photothermal treatment (PTT) and they can be combined together (Fig. 1c) for more effective treatments [14].

In difference with micro or bulk counterparts, materials synthesized and engineered on nanoscale usually have novel characteristics which may be favorable in biological systems for interaction with cell surface and intercellular structures. Nowadays the nanoscale materials have become strong candidates for medical treatments as carriers for drugs, therapy and for the detection of diseases. In cancer or tumor treatment, nanoparticles (NPs) have recently been considered as a promising new approach [15]. Nanomedicine requires a multidisciplinary attitude and its understanding requiring knowledge of ethical, physical, chemical, physiological and biological aspects. Nanotechnology promises to revolutionize the area of cancer/tumor treatment with a wide spectrum of nanostructures including polymers, dendrimers, lipids, organometallic, carbon based materials, several inorganic nanomaterials (iron oxide, Au, Ag, semiconductor quantum dots (QDs) contributing to development of treatments with different physical process and mechanisms of action [15]. An approach to the selection of nanomaterials should consider biodistribution, toxicity (short and long term), size control, surface chemistry, their behavior in biological systems and the use of nanomaterials with their unique properties can open a new set of opportunity for medicine. Here, NPs can have therapeutic as well as diagnostic properties to be designed to carry a large therapeutic “payload [4]. They can also be modified with targeting ligands which yield high affinity and specificity for target cells to deliver highly active chemotherapy and hyperthermia with cellular precision. The complex structure of NPs can be made to accommodate multiple active molecules simultaneously allowing combinatorial cancer therapy with different drugs [16] and biomimetic NPs can bypass cellular membranes as well as overcome drug resistance mechanism [17,18]. Currently, NPs and nanoparticulate formulations have been integrated into cancer therapeutics and ongoing clinical trials with improved efficacy and reduced toxicity [19].

Thermal treatments mediated with nanomaterials can be classified through the process used to generate the therapeutic effect a slight activated in the photothermal and photodynamic therapies or magnetically induced for the magnetothermal therapy [18,20]. Magnetothermal therapy is based on different mechanisms including hysteresis loss, Neel relaxation and Brown relaxation to convert the energy of an external magnetic field into heat. A typical method of delivering the NPs to the tumor site is the direct injection in the tumor area followed by diffusion in the damaged tissues [21]. The first clinical results in the field of MHT were obtained by Jordan et al [22] against brain tumor using superparamagnetic iron-oxide coated by aminosilane. A benefit of using magnetic nanostructures for MHT is the simultaneously use of either being contrast agent in magnetic resonance imaging (MRI) or acting as heat source when exposed to specific frequencies. On the negative side, MHT may cause protein denaturation, DNA damage, signaling interruption, cell growth inhibition and apoptosis [23].

PTT, or optical hyperthermia, uses the energy of laser to trigger the action of either photothermal conversion agents or specific physical phenomena to generate heat causing thermal ablation of cancer cells [24]. A field of PTT study has expanded since the beginning of the millennia with the development of easily producible Au nanostructures (e.g., rods, cubes) [25], and nowadays it is extended to nanostructures with a variety of different elements or materials. Nanomaterials used in PTT are generally characterized by a great efficiency in photothermal conversion for wavelength in the near infrared (NIR) to exploit the optical window of living tissues [26]. In addition, the materials also need to have high performance, especially when applied to in vivo, a low toxicity and tumor targeting properties. NIR lasers are the main energy source for PTT which can penetrate through the tissues and be converted into heat by the nanomaterials (Fig. 1). Using laser directly to ablate tumor tissues would require high energy settings causing unintended damage to normal tissues. The introduction of a photothermal conversion agents allows the use of low energy laser able to penetrate healthy tissues without causing heat damages [16]. Several necessary characteristics are important for such agents including photostability, biocompatibility, large absorption coefficient and NIR absorption. Metals have different optical properties from standard dielectric materials (based on oxides, fluorides, nitrides etc.) and among them nanostructured Au is the most promising photothermal metallic agent. Here, the heating mainly involves surface plasmon generation or localized surface plasmon resonance from the interaction of light with metals. One of the traditional draw backs of PTT was the necessity of the laser to be able to penetrate the healthy tissues without damaging them or loosing too much power (due to scattering). This limitation has been recently overcome by moving the light source inside the patient with the use of fiber optic waveguides. With a powerful laser source, the output, however, was relatively weak limited from fraction of watt to few watts for direct laser ablation or even lower for longer time when used for particles mediated hyperthermia [28].

The difference between MHT and PTT is the attainable tissue penetration. PTT is only able to treat tumors seated at the surface or a few millimeters below the tissue level because of limited tissue penetration of light [29] while MHT can treat tumors seated at any depth thanks to the large tissue penetration ability of the magnetic field [30]. Moreover, the contactless use of alternating AC magnetic field enables a controllable remote treatment to eliminate tumors that are inaccessible by PTT. The continuous effort of working on the subject of cancer treatments using thermal approach has been linked specially with the synthesis of nanomaterials focusing on high degree of shape-size tunability, surface modifications and bioconjugations with NPs. At the moment, a very few clinical centers use MHT/PTT for anticancer therapy, but there are a large number of particles and protocols in pre-clinical or in the process of being approved in Europe and USA for clinical use [31,32]. The pursuit of innovative, multifunctional, more efficient and safer treatments is a major challenge in preclinical NP-mediated thermotherapeutic research, and it is important to search for “dual” materials to act as both magnetic and photothermal agents. In this review, we are aiming to provide comprehensive information about magnetic and photothermal hyperthermia including the processes involved in their mechanisms, on the factors affecting the efficiency, the biological interactions as well as details on the instrumentations used for the therapies. We also review both the therapies at clinical levels and the combined therapy showing the research work on this hot topic.

Section snippets

Magnetic-induced hyperthermia

The primary target of hyperthermia is to deliver heat to kill cancerous cells at clinically adequate temperatures and to limit the damage to healthy tissue. Nanotechnology has provided a novel and original solution allows targeting regions in the body otherwise difficult to reach and thanks to their nanoscale design they open the possibility to conjugate biomolecules like antibodies for a more effective therapy or to accomplish specific targeting [33]. Magnetic-induced hyperthermia is minimally

Photo-induced hyperthermia

The use of radiative sources to induce hyperthermia have been established to treat surface lesions and tumors since the beginning of the 20thcentury. Initially radiative treatments were based on infra-red (IR) lamps and photosensitizer to induce thermal damage or oxidative stress on the affected areas of the patients, but they could only be applied on entire sections of the body and so it greatly increases the opportunity of collateral damage on healthy tissues and the stress on the patient.

Comparison between magnetic and photo-induced hyperthermia and their combinatorial effect

Classical methodology for the treatment of cancer are effective but presents serious problem of toxicity damaging healthy cells and DNA which may cause secondary tumors. Hyperthermia driven by nanomaterials have been used for a more precise strategy with interesting results for a wide variety of materials and shapes against cancer cells. Besides generating heat, functional NPs can also be targeted to the tumor to release active drugs when it is triggered by an external stimulus.

The MHT or PTT

Prerequisites for hyperthermia treatment in the clinic

The methods and procedure for the production and functionalization of NPs for MHT and PTT have greatly improved in the last two decades, but these systems are still far from being ready for clinical uses. One of the obstacles for in vivo administration is the difficulty to measure and guarantee the stability of the material exposed to the complex conditions of the various biofluid and tissues present in a real body. Ideally, nanomaterials should be inert to the passage through the body, be able

Conclusion and future perspectives

To summarize, we have reviewed a detail of thermal treatments and their diverse applications. The aim of thermal treatment using nanoscaled materials is the ablation of tumor and killing of cancer cells. A description and mechanism of MHT and various spectroscopic mechanism of PTT has been provided together in this review. Recent examples from clinical trials has been taken to explain the importance of the topic and under clinical trial nanomaterials. Technical information regarding

Declaration of Competing Interest

There are no conflicts of interest to declare.

Acknowledgement

FR & NTKT thanks Engineering and Physical Sciences Research Council (EPSRC, grant EP/M018016/1) for funding, LDT, FR & NTKT thanks Asian Office of Aerospace Research and Development grant (AOARD, grant FA2386-17-1-4042) for funding. NS thanks to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil for the post-doctoral fellowship (PDJ 152208/2018-6). The authors thank Sarveena and Nina Christou for insightful discussion.

Surender Kumar Sharma is a faculty in Materials Science at Department of Physics, Faculty of Science & Technology, The University of the West Indies (UWI), Trinidad & Tobago. Before joining UWI, he worked as a Professor Adjunto (IV) at Department of Physics, Federal University of Maranhão (UFMA), Brazil (2014–2019). He has received his Ph.D. in Physics from Himachal Pradesh University, Shimla, India in 2007. He worked on different research/academic positions in Brazil, France, Czech Republic,

References (233)

  • S. Jha et al.

    Achiev. Life Sci.

    (2016)
  • M. Drakopoulou et al.

    Curr. Opin. Pharmacol.

    (2018)
  • A. LeBrun et al.

    J. Therm. Biol.

    (2016)
  • S. Jha et al.

    Achiev. Life Sci.

    (2016)
  • A. Singh et al.

    Drug Discov. Today

    (2014)
  • R.A. Revia et al.

    Mater. Today

    (2016)
  • S. Laurent et al.

    Adv. Colloid Interface Sci.

    (2011)
  • R. Hergt et al.

    J. Magn. Magn. Mater.

    (2007)
  • R.R. Shah et al.

    J. Magn. Magn. Mater.

    (2015)
  • R.E. Rosensweig

    J. Magn. Magn. Mater.

    (2002)
  • A.E. Deatsch et al.

    J. Magn. Magn. Mater.

    (2014)
  • M. Harabech et al.

    J. Magn. Magn. Mater.

    (2017)
  • C.S.S.R. Kumar et al.

    Adv. Drug Deliv. Rev.

    (2011)
  • P.H. Linh et al.

    J. Magn. Magn. Mater.

    (2018)
  • R.M. Patil et al.

    Biochem. Biophys. Reports

    (2018)
  • Z. Nemati et al.

    J. Alloys Compd.

    (2017)
  • E.C. Abenojar et al.

    Prog. Nat. Sci.: Mater. Int.

    (2016)
  • M. Suto et al.

    J. Magn. Magn. Mater.

    (2009)
  • H. Köçkar et al.

    J. Magn. Magn. Mater.

    (2019)
  • S. Sotoma et al.

    ChemMedChem

    (2018)
  • G. Kucsko et al.

    Nature

    (2013)
  • A. Szasz, O. Szasz, N. Szasz, Hyperth. Cancer Treat. A Prim., Springer US, Boston, MA, n.d., pp....
  • A.E. Dunn et al.

    Nanoscience

    (2013)
  • R.W.Y. Habash et al.

    Crit. Rev. Biomed. Eng.

    (2006)
  • D. Jaque et al.

    Nanoscale

    (2014)
  • Z. Behrouzkia et al.

    Oman. Med. J.

    (2016)
  • P. Chakravarty et al.

    Proc. Natl. Acad. Sci.

    (2008)
  • A. Hervault et al.

    Nanoscale

    (2014)
  • A. Espinosa et al.

    ACS Nano

    (2016)
  • S.R. Grobmyer et al.

    Methods Mol Biol

    (2010)
  • E. Blanco et al.

    Nat. Biotechnol.

    (2015)
  • D. Jaque et al.

    Nanoscale

    (2014)
  • A. Sharma et al.

    J. Drug Target.

    (2018)
  • N. Lee et al.

    Chem. Rev.

    (2015)
  • A. Jordan et al.

    J. Nanosci. Nanotechnol.

    (2007)
  • A.B. Salunkhe et al.

    Curr. Top. Med. Chem.

    (2014)
  • A. Espinosa et al.

    Nanoscale

    (2015)
  • E.C. Dreaden et al.

    Chem. Soc. Rev.

    (2012)
  • Z. Zhang et al.

    Theranostics

    (2013)
  • Z.-C. Wu et al.

    Adv. Funct. Mater.

    (2015)
  • Z. Zhang et al.

    J. Am. Chem. Soc.

    (2014)
  • A.N. Bashkatov et al.

    J. Phys. D Appl. Phys.

    (2005)
  • E. Myrovali et al.

    Sci. Rep.

    (2016)
  • C.L. Ventola

    Pharm. Therapeutics

    (2017)
  • D. Ortega et al.
  • E.A. Périgo et al.

    Appl. Phys. Rev.

    (2015)
  • S. Dutz et al.

    Int. J. Hyperthermia

    (2013)
  • R.K. Gilchrist et al.

    Ann. Surg.

    (1957)
  • M. Osaci et al.
    (2017)
  • M.S. Carrião et al.

    Nanoscale

    (2016)
  • Cited by (186)

    View all citing articles on Scopus

    Surender Kumar Sharma is a faculty in Materials Science at Department of Physics, Faculty of Science & Technology, The University of the West Indies (UWI), Trinidad & Tobago. Before joining UWI, he worked as a Professor Adjunto (IV) at Department of Physics, Federal University of Maranhão (UFMA), Brazil (2014–2019). He has received his Ph.D. in Physics from Himachal Pradesh University, Shimla, India in 2007. He worked on different research/academic positions in Brazil, France, Czech Republic, India and Mexico from 2007-2014. His research interests include magnetic nanohybrids, their synthesis, characterization and utilization in magnetic and biomedical applications.

    Navadeep Shrivastava has obtained his Ph.D. from Federal University of Maranhão, Brazil under guidance of Prof. Dr. Surender Kumar Sharma in 2017. He majored in Mathematics and Physics in his Bachelor of Science (2010) and Master of Science in Physics (2013) from University of Allahabad, India. During his Ph.D., he worked on hybrid magnetic-luminescent nanomaterials and their application in radiation detection. His expertise lies in the syntheses and characterizations of multifunctional nanomaterials based on magnetic nanoparticles and rare-earth spectroscopy. Currently, he is involved in research activities as a Post-Doctoral Researcher, at Institute of Physics, Federal University of Goiás, Brazil with a major research focus in design of multifunctional colloidal nanohybrids for thermal nanomedicine, multimodal imaging and nanothermometry.

    Francesco Rossi is a PhD student of the Biophysics Group at the Department of Physics and Astronomy at UCL. He achieved is BSc and MSc at the university of Florence (Italy) and spent two years working as laboratory technician for Procarta Biosystems (UK) and participated at the A*STAR exchange project between UCL and IMRE of Singapore from 2016 to 2018. His research consists of developing anisotropic nanomaterials able to interact with light. Light activated particles can be used to create auto sterilizing polymers to be used in medical and food industry.

    Le Duc Tung received his Ph.D. degree in Physics from University of Amsterdam in 1998. He was a postdoctoral fellow at the University of New Orleans (2001–2003), University of Warwick (2003–2007), University of Liverpool (2007–2010). Currently he is a senior research fellow at Biophysics Group, Department of Physics & Astronomy, University College London. His research interests are in magnetism and magnetic materials and recently focused on biomedical applications of magnetic nanoparticles.

    Professor Nguyen T. K. Thanh, FRSC FIMMM FInstP FRSB (http://www.ntk-thanh.co.uk) held a prestigious Royal Society University Research Fellowship (2005–2014) and was promoted to Full Professor of nanomaterials in 2013 at University College London. She received 2019 Royal Society Rosalind Franklin Award. She is Editor-in-chief of the Royal Society of Chemistry book Series, Nanoscience and Nanotechnology. She conducts cutting edge interdisciplinary and innovative research on the design, chemical synthesis, physical characterization of magnetic and plasmonic nanomaterials for biomedical applications. In collaboration with physicists, material scientists, chemical engineers she has produced the next generation of nanoparticles with very high magnetic moment, fine tuning Au nanorods, novel hybrid and multifunctional nanostructures. Detailed mechanistic studies of their formation by sophisticated and advanced analysis of the nanostructure allows tuning of the physical properties at the nanoscale; these can subsequently be exploited for diagnosis and treatment of various diseases in collaboration with biologists, biochemists and clinicians. To date she has published 107 peer reviewed journal articles and book chapters, books and theme issues. Among them 9 papers were featured as cover pages. Her research has accrued ∼9000 citations, with an average over 80 citation per item, giving her an i10 of 50, and notably she has 12 papers with over 100 citations, with 1 research paper attracting an exceptional > 2300 citations.

    View full text